BNP/CALL/MERCK & CO./130/0.1/19.12.25 Share Price

Warrant

DE000PC1LLT0

Market Closed - Börse Stuttgart 12:43:42 28/06/2024 pm IST
1.58 EUR -1.25% Intraday chart for BNP/CALL/MERCK & CO./130/0.1/19.12.25
Current month+21.54%
1 month+5.33%
Date Price Change
28/24/28 1.58 -1.25%
27/24/27 1.6 -6.98%
26/24/26 1.72 -1.15%
25/24/25 1.74 +10.83%
24/24/24 1.57 +1.95%

Delayed Quote Börse Stuttgart

Last update June 28, 2024 at 12:43 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC1LLT
ISINDE000PC1LLT0
Date issued 11/12/2023
Strike 130 $
Maturity 19/12/2025 (539 Days)
Parity 10 : 1
Emission price 0.41
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.82
Lowest since issue 0.49
Spread 0.01
Spread %0.77%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
123.8 USD
Average target price
142.7 USD
Spread / Average Target
+15.25%
Consensus